INCY INCYTE CORP

Incyte Analyst and Investor Event to Highlight Clinical Data Presentations from ASCO 2017

WILMINGTON, Del.--(BUSINESS WIRE)--

Incyte Corporation (Nasdaq:INCY) announced today that data from ongoing investigational studies of epacadostat in combination with pembrolizumab (ECHO-202) and nivolumab (ECHO-204) in multiple tumor types will be discussed at an Analyst and Investor Event this evening, Monday, June 5, 2017. These data are from posters and presentations at the American Society for Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.

A live webcast of the event will begin on June 5, 2017 at 7:30 p.m. CT (8:30 p.m. ET) and will be accessible via www.incyte.com in the Investors section under “Events and Presentations”. Investors interested in listening to the live webcasts should log on before the start time to download any required software.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

EN
05/06/2017

Underlying

INCYINCYTE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INCYTE CORP

Free Trial
INCY INCYTE CORP

Incyte Corp: 3 directors

Three Directors at Incyte Corp sold/sold after exercising options 17,321 shares at between 68.470USD and 69.860USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...

07/16/25 July 16, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.03
INCY INCYTE CORP
ILMN ILLUMINA INC. ... (+36)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

INCY INCYTE CORP
ILMN ILLUMINA INC.
KMX CARMAX INC.
TFX TELEFLEX INCORPORATED
OMCL OMNICELL INC.
MDT MEDTRONIC PLC
MD MEDNAX INC.
LAD LITHIA MOTORS INC. CLASS A
JNJ JOHNSON & JOHNSON
GILD GILEAD SCIENCES INC.
EXPE EXPEDIA GROUP INC.
CNMD CONMED CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
BXP BOSTON PROPERTIES INC.
ATSG AIR TRANSPORT SERVICES GROUP INC.
APPS DIGITAL TURBINE
ANGO ANGIODYNAMICS INC.
AMPH AMPHASTAR PHARMACEUTICALS INC
AUP AURINIA PHARMACEUTICALS INC.
CRI CARTER'S INC.
LBRDA LIBERTY BROADBAND CORP. CLASS A
ASIX ADVANSIX INC.
CSCO CISCO SYSTEMS INC.
KREF KKR REAL ESTATE FINANCE TRUST
ROKU ROKU INC. CLASS A
PGC PEAPACK-GLADSTONE FINANCIAL CORP.
ZM ZOOM VIDEO COMMUNICATIONS INC. CLASS A
NVST ENVISTA HOLDINGS
MTCH MATCH GROUP INC.
GEVO GEVO
CGEM CULLINAN ONCOLOGY INC
OLPX OLAPLEX HLDGS INC
TSE TRINSEO PLC
EXFY EXPENSIFY INC
CCI CALAMOS GLB CNVRTBL & DYNMC INC COM
CSOAD COASTAL CONTACTS INC COM
08/28/24 August 28, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.03
INCY INCYTE CORP
ANTM ANTHEM INC. ... (+33)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

INCY INCYTE CORP
ANTM ANTHEM INC.
TSN TYSON FOODS INC. CLASS A
RYAM RAYONIER ADVANCED MATERIALS INC
RY. ROYAL BANK OF CANADA
MRK MERCK & CO. INC.
LAZ LAZARD LTD CLASS A
KHC KRAFT HEINZ COMPANY
K KELLOGG COMPANY
GIS GENERAL MILLS INC.
GILD GILEAD SCIENCES INC.
FIBK FIRST INTERSTATE BANCSYSTEM INC. CLASS A
CVS CVS HEALTH CORPORATION
CPB CAMPBELL SOUP COMPANY
CNC CENTENE CORPORATION
CF CF INDUSTRIES HOLDINGS INC.
CAG CONAGRA BRANDS INC.
BGS B&G FOODS INC.
ARWR ARROWHEAD PHARMACEUTICALS INC.
ABUS ARBUTUS BIOPHARMA CORP.
VIRT VIRTU FINANCIAL INC. CLASS A
FDP FRESH DEL MONTE PRODUCE INC.
CENX CENTURY ALUMINUM COMPANY
KMI KINDER MORGAN INC CLASS P
KO COCA-COLA COMPANY
LMT LOCKHEED MARTIN CORPORATION
SJM J.M. SMUCKER COMPANY
ABBV ABBVIE INC.
MRNA MODERNA INC.
VTRS VIATRIS INC.
RLAY RELAY THERAPEUTICS
RNA AVIDITY BIOSCIENCES
DOLE DOLE PLC
01/04/24 January 4, 2024 1 EN
Brian Moretta ... (+4)
  • Brian Moretta
  • Mark Thomas
  • Martin Hall
  • Riccardo Bindi
AMGN AMGEN INC.
INCY INCYTE CORP ... (+61)

Hardman & Co Monthly: April 2023

Feature article: 2022 Pharma Statistics - 8.7% growth – but worrying signs An efficient reporting system has seen all the listed multinational pharmaceutical companies announcing results for 2022, which has given us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of the global and US rankings of the top 20 drug companies for 2022. 2022 was characterised by 8.7% underlying growth, offset by a large forex impact (-12%), due to USD stren...

AMGN AMGEN INC.
INCY INCYTE CORP
IPN IPSEN SA
NOVN NOVARTIS AG
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
REGN REGENERON PHARMACEUTICALS INC.
LLY MERCK & CO. INC.
JNJ ELI LILLY AND COMPANY
J7Z JOHNSON & JOHNSON
HZNP JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
GILD HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
BMY GILEAD SCIENCES INC.
BIIB BRISTOL-MYERS SQUIBB COMPANY
FEV BIOGEN INC.
IBT FIDELITY EUROPEAN VALUES PLC
FCSS INTERNATIONAL BIOTECHNOLOGY TRUST PLC
FSV FIDELITY CHINA SPECIAL SITUATIONS PLC
FJV FIDELITY SPECIAL VALUES PLC
FAS FIDELITY JAPAN TRUST
AVO FIDELITY ASIAN VALUES PLC
CLIG ADVANCED ONCOTHERAPY
MRK CITY OF LONDON INVESTMENT GROUP
NOVO B MERCK KGAA
novob NOVO NORDISK A/S CLASS B
RECI NOVO NORDISK
SAN REAL ESTATE CREDIT INVESTMENTS
UCB SANOFI
HIK UCB S.A.
PIN HIKMA PHARMACEUTICALS PLC
PFIZER PANTHEON INTERNATIONAL
4506 PFIZER
4523 SUMITOMO DAINIPPON PHARMA CO. LTD.
4507 EISAI CO. LTD.
4568 SHIONOGI & CO. LTD.
VTAS DAIICHI SANKYO COMPANY LIMITED
STX VOLTA FINANCE (GBP)
4502 SHIELD THERAPEUTICS
HAT TAKEDA PHARMACEUTICAL CO. LTD.
OCI H&T GROUP
4578 OAKLEY CAPITAL INVESTMENTS
APAX OTSUKA HOLDINGS CO. LTD.
4503 APAX GLOBAL ALPHA
ICGT ASTELLAS PHARMA INC.
UTHR ICG ENTERPRISE TRUST
PFE UNITED THERAPEUTICS CORPORATION
AZN PFIZER INC.
GLAXO ASTRAZENECA PLC
ABBV GLAXOSMITHKLINE PHARMACEUTICALS
VRX CN ASTELLAS PHARMA INC
MRNA ABBVIE INC.
TXG BAUSCH HEALTH COMPANIES INC.
NOVO MODERNA INC.
VTRS 10X GENOMICS INC CLASS A
4568.T NOVO NORDISK A/S-B
ME VIATRIS INC.
OCL DAIICHI SANKYO COMPANY
LUND A LIMITED
23ANDME HLDG CO
OAKLEY CAPITAL
H. LUNDBECK A/S
04/05/23 April 5, 2023 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.03
AMGN AMGEN INC.
INCY INCYTE CORP ... (+13)

Vermilion Compass: Weekly Equity Strategy

Indexes Form Bear Flag Patterns Within Downtrends We continue to view the price action over the past month as a bear market bounce in the S&P 500, Nasdaq 100 (QQQ), and Russell 2000 (IWM), as each index appears to be forming a bearish flag pattern. Until the S&P 500, QQQ, and IWM can break above their YTD downtrends, we remain bearish, and believe investors should be using rallies to reduce overall exposure in preparation for new lows ahead... see charts below. U.S. Dollar, 10-Yr Treasury Yiel...

AMGN AMGEN INC.
INCY INCYTE CORP
AMN AMN HEALTHCARE SERVICES INC.
VRTX VERTEX PHARMACEUTICALS INCORPORATED
NOVA NOVO NORDISK A/S ADS
MRK MERCK & CO. INC.
LLY ELI LILLY AND COMPANY
JNJ JOHNSON & JOHNSON
BMY BRISTOL-MYERS SQUIBB COMPANY
BIIB BIOGEN INC.
CCRN CROSS COUNTRY HEALTHCARE INC.
PFE PFIZER INC.
ABBV ABBVIE INC.
07/12/22 July 12, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch